Skip to content

Thalidomide

Thalidomide appears in one listed capsule product, Thalix. The Antineoplastic classification provides context for its listed use for Multiple Myeloma. Product details identify the specific presentation and ingredient composition, while the catalogue brings its stated strength and formulation together for comparison.

Thalix

Multiple Myeloma, Erythema Nodosum Leprosum

50mg

Intended to relieve multiple myeloma proliferation to support clinical remission and target neoplastic pathways.

From$2.98/ capsuleView

Which conditions are associated with Thalidomide?

One listed use is Multiple Myeloma. Another treatment context is Erythema Nodosum Leprosum. Related medicines appear within Oncology Support.

Important safety information for Thalidomide

Information about Thalidomide on this page is an educational overview, not medical advice. Products can differ in formulation, strength, and directions, and this content does not authorise clinical application or unsupervised use. Review the labelling for each product and speak with a healthcare professional whenever clinical judgement is needed. Product-specific contraindications, interactions, and reactions should be checked in the product labelling and verified clinical sources.